A Prospective Study of 18FDG-PET With CT Coregistration for Radiation Treatment Planning of Lymphomas and Other Hematologic Malignancies

被引:11
|
作者
Terezakis, Stephanie A. [1 ,4 ]
Schoeder, Heiko [2 ]
Kowalski, Alexander [1 ]
McCann, Patrick [1 ]
Lim, Remy [2 ]
Turlakov, Alla [2 ]
Gonen, Mithat [3 ]
Barker, Chris [1 ]
Goenka, Anuj [1 ]
Lovie, Shona [1 ]
Yahalom, Joachim [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Nucl Med, New York, NY 10065 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Stat, New York, NY 10065 USA
[4] Johns Hopkins Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD USA
关键词
POSITRON-EMISSION-TOMOGRAPHY; NON-HODGKINS-LYMPHOMA; RADIOTHERAPY; GUIDELINES; INDOLENT; FIELDS; IMPACT; PET;
D O I
10.1016/j.ijrobp.2014.02.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: This prospective single-institution study examined the impact of positron emission tomography (PET) with the use of 2-[F-18] fluoro-2-deoxyglucose and computed tomography (CT) scan radiation treatment planning (TP) on target volume definition in lymphoma. Methods and Materials: 118 patients underwent PET/CT TP during June 2007 to May 2009. Gross tumor volume (GTV) was contoured on CT-only and PET/CT studies by radiation oncologists (ROs) and nuclear medicine physicians (NMPs) for 95 patients with positive PET scans. Treatment plans and dose-volume histograms were generated for CT-only and PET/CT for 95 evaluable sites. Paired t test statistics and Pearson correlation coefficients were used for analysis. Results: 70 (74%) patients had non-Hodgkin lymphoma, 10 (11%) had Hodgkin lymphoma, 12 (10%) had plasma-cell neoplasm, and 3 (3%) had other hematologic malignancies. Forty-three (45%) presented with relapsed/refractory disease. Forty-five (47%) received no prior chemotherapy. The addition of PET increased GTV as defined by ROs in 38 patients (median, 27%; range, 5%-70%) and decreased GTV in 41 (median, 39.5%; range, 5%-80%). The addition of PET increased GTV as defined by NMPs in 27 patients (median, 26.5%; range, 5%-95%) and decreased GTV in 52 (median, 70%; range, 5%-99%). The intraobserver correlation between CT-GTV and PET-GTV was higher for ROs than for NMPs (0.94, P <.01 vs 0.89, P <.01). On the basis of Bland-Altman plots, the PET-GTVs defined by ROs were larger than those defined by NMPs. On evaluation of clinical TPs, only 4 (74%) patients had inadequate target coverage (D95 < 95%) of the PET-GTV defined by NMPs. Conclusions: Significant differences between the RO and NMP volumes were identified when PET was coregistered to CT for radiation planning. Despite this, the PET-GTVdefined by ROs and NMPs received acceptable prescription dose in nearly all patients. However, given the potential for a marginal miss, consultation with an experienced PET reader is highly encouraged when PET/CT volumes are delineated, particularly for questionable lesions and to assure complete and accurate target volume coverage. (C) 2014 Elsevier Inc.
引用
收藏
页码:376 / 383
页数:8
相关论文
共 50 条
  • [31] Prognostic factors associated with 18FDG-PET/CT in esophageal squamous cell carcinoma after trimodality treatment
    Feng, Wei-Hsiang
    Chen, Ying-Yi
    Kuo, Yen-Shou
    Lin, Kuan-Hsun
    Tsai, Yuan-Ming
    Wu, Ti-Hui
    Huang, Hsu-Kai
    Huang, Tsai-Wang
    BMC CANCER, 2022, 22 (01)
  • [32] Prognostic factors associated with 18FDG-PET/CT in esophageal squamous cell carcinoma after trimodality treatment
    Wei-Hsiang Feng
    Ying-Yi Chen
    Yen‐Shou Kuo
    Kuan-Hsun Lin
    Yuan-Ming Tsai
    Ti-Hui Wu
    Hsu-Kai Huang
    Tsai-Wang Huang
    BMC Cancer, 22
  • [33] Impact of pretreatment second look 18FDG-PET/CT on stage and treatment changes in head and neck cancer
    Elicin, Olgun
    Vollnberg, Bernd
    Shelan, Mohamed
    Riggenbach, Elena
    Bojaxhiu, Beat
    Mathier, Etienne
    Giger, Roland
    Aebersold, Daniel M.
    Klaeser, Bernd
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2021, 31 : 8 - 13
  • [34] IMRT with 18FDG-PET\CT based simultaneous integrated boost for treatment of nodal positive cervical cancer
    Cihoric, Nikola
    Tapia, Coya
    Krueger, Kamilla
    Aebersold, Daniel M.
    Klaeser, Bernd
    Loessl, Kristina
    RADIATION ONCOLOGY, 2014, 9
  • [35] Efficacy of 18FDG-PET/CT in Detecting Synchronous Malignancies in Patients With Head and Neck Cancer: A Systematic Review and Meta-analysis
    Ershadifar, Soroush
    Larsson, Jordan
    Young, Kurtis
    Abouyared, Marianne
    Bewley, Arnaud
    Birkeland, Andrew C.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2024, 171 (06) : 1639 - 1649
  • [36] Evaluating the Use of 18F-FDG PET CT for External Beam Radiotherapy Planning in Gynaecological Malignancies
    Ashleigh Kerr
    Nicholas Reed
    Rosie Harrand
    Kathryn Graham
    Azmat H. Sadozye
    Current Oncology Reports, 2018, 20
  • [37] Impact of 18FDG-PET/CT on biological target volume (BTV) definition for treatment planning for non-small cell lung cancer patients
    Devic, Slobodan
    Tomic, Nada
    Faria, Sergio
    Dean, Geoffrey
    Lisbona, Robert
    Parker, William
    Kaufman, Chris
    Podgorsak, Ervin B.
    NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT, 2007, 571 (1-2): : 89 - 92
  • [38] Low incidence of abnormal 18FDG-PET in children with new-onset partial epilepsy -: A prospective study
    Gaillard, WD
    Kopylev, L
    Weinstein, S
    Conry, J
    Pearl, PL
    Spanaki, MV
    Fazilat, S
    Fazilat, S
    Venzina, LG
    Dubovsky, E
    Theodore, WH
    NEUROLOGY, 2002, 58 (05) : 717 - 722
  • [39] Evaluating the Use of 18F-FDG PET CT for External Beam Radiotherapy Planning in Gynaecological Malignancies
    Kerr, Ashleigh
    Reed, Nicholas
    Harrand, Rosie
    Graham, Kathryn
    Sadozye, Azmat H.
    CURRENT ONCOLOGY REPORTS, 2018, 20 (10)
  • [40] Comparison of Locally Advanced Pancreatic Cancer Target Definition Methods on 18FDG-PET images for Radiotherapy Treatment Planning
    Eccles, C. L.
    Vallis, K. A.
    Brunner, T. B.
    McKenna, W. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S732 - S732